Towards precision medicine in systemic lupus erythematosus

27Citations
Citations of this article
105Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Systemic lupus erythematosus (SLE) is a remarkable condition characterised by diversity amongst its clinical features and immunological abnormalities. In this review, we attempt to capture the major immunological changes linked to the pathophysiology of lupus and discuss the challenge it presents in moving towards the concept of precision medicine. Currently broadly similar types of drugs, e.g., steroids, immunosuppressives, hydroxychlor-oquine are used to treat many of the diverse clinical features of SLE. We suspect that, as the precise immunopathological abnormalities differ between the various organs/systems in lupus patients, it will be some time before precision medicine can be fully applied to SLE.

Cite

CITATION STYLE

APA

Lever, E., Alves, M. R., & Isenberg, D. A. (2020). Towards precision medicine in systemic lupus erythematosus. Pharmacogenomics and Personalized Medicine. Dove Medical Press Ltd. https://doi.org/10.2147/PGPM.S205079

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free